Insider Transactions in Q1 2023 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.53%
|
$409,200
$372.46 P/Share
|
|
Jan 03
2023
|
Craig B. Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+11.14%
|
-
|
|
Jan 03
2023
|
N Anthony Coles Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.6%
|
-
|
|
Jan 03
2023
|
Huda Y Zoghbi Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.69%
|
-
|
|
Jan 03
2023
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
330
+6.35%
|
-
|